View in EDS HTML Full Text PDF Full Text

Capivasertib and fulvestrant for patients with HR-positive/HER2-negative advanced breast cancer: analysis of the subgroup of patients from Japan in the phase 3 CAPItello-291 trial.

Saved in:
Bibliographic Details
Title: Capivasertib and fulvestrant for patients with HR-positive/HER2-negative advanced breast cancer: analysis of the subgroup of patients from Japan in the phase 3 CAPItello-291 trial.
Authors: Tokunaga E; National Hospital Organization (NHO) Kyushu Cancer Center, Fukuoka, Japan. erikotokunaga.nkcc@gmail.com., Iwata H; Aichi Cancer Center Hospital, Aichi, Japan., Itoh M; Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan., Taira T; Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima, Japan., Toyama T; Nagoya City University Hospital, Aichi, Japan., Mizuno T; Mie University Hospital, Mie, Japan., Osaki A; Saitama Medical University International Medical Center, Saitama, Japan., Yanagita Y; Gunma Prefectural Cancer Center, Gunma, Japan., Nakamura S; Showa University Hospital, Tokyo, Japan., Nakamura R; Chiba Cancer Center, Chiba, Japan., Sambe T; Oncology R&D, AstraZeneca, Osaka, Japan., Ozaki T; Oncology R&D, AstraZeneca, Osaka, Japan., Schiavon G; Oncology R&D, AstraZeneca, Cambridge, UK., Howell SJ; The Christie NHS Foundation Trust, Manchester, UK., Toi M; Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.
Source: Breast cancer (Tokyo, Japan) [Breast Cancer] 2025 Jan; Vol. 32 (1), pp. 132-143. Date of Electronic Publication: 2024 Oct 08.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39379782
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Capivasertib and fulvestrant for patients with HR-positive/HER2-negative advanced breast cancer: analysis of the subgroup of patients from Japan in the phase 3 CAPItello-291 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tokunaga+E%22">Tokunaga E</searchLink>; National Hospital Organization (NHO) Kyushu Cancer Center, Fukuoka, Japan. erikotokunaga.nkcc@gmail.com.<br /><searchLink fieldCode="AU" term="%22Iwata+H%22">Iwata H</searchLink>; Aichi Cancer Center Hospital, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Itoh+M%22">Itoh M</searchLink>; Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Taira+T%22">Taira T</searchLink>; Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima, Japan.<br /><searchLink fieldCode="AU" term="%22Toyama+T%22">Toyama T</searchLink>; Nagoya City University Hospital, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Mizuno+T%22">Mizuno T</searchLink>; Mie University Hospital, Mie, Japan.<br /><searchLink fieldCode="AU" term="%22Osaki+A%22">Osaki A</searchLink>; Saitama Medical University International Medical Center, Saitama, Japan.<br /><searchLink fieldCode="AU" term="%22Yanagita+Y%22">Yanagita Y</searchLink>; Gunma Prefectural Cancer Center, Gunma, Japan.<br /><searchLink fieldCode="AU" term="%22Nakamura+S%22">Nakamura S</searchLink>; Showa University Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nakamura+R%22">Nakamura R</searchLink>; Chiba Cancer Center, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Sambe+T%22">Sambe T</searchLink>; Oncology R&D, AstraZeneca, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Ozaki+T%22">Ozaki T</searchLink>; Oncology R&D, AstraZeneca, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Schiavon+G%22">Schiavon G</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Howell+SJ%22">Howell SJ</searchLink>; The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Toi+M%22">Toi M</searchLink>; Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100888201%22">Breast cancer (Tokyo, Japan)</searchLink> [Breast Cancer] 2025 Jan; Vol. 32 (1), pp. 132-143. <i>Date of Electronic Publication: </i>2024 Oct 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Maruzen+Co%22">Maruzen Co </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>100888201 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1880-4233 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213406868%22">13406868 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39379782
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12282-024-01640-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 132
    Titles:
      – TitleFull: Capivasertib and fulvestrant for patients with HR-positive/HER2-negative advanced breast cancer: analysis of the subgroup of patients from Japan in the phase 3 CAPItello-291 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tokunaga E
      – PersonEntity:
          Name:
            NameFull: Iwata H
      – PersonEntity:
          Name:
            NameFull: Itoh M
      – PersonEntity:
          Name:
            NameFull: Taira T
      – PersonEntity:
          Name:
            NameFull: Toyama T
      – PersonEntity:
          Name:
            NameFull: Mizuno T
      – PersonEntity:
          Name:
            NameFull: Osaki A
      – PersonEntity:
          Name:
            NameFull: Yanagita Y
      – PersonEntity:
          Name:
            NameFull: Nakamura S
      – PersonEntity:
          Name:
            NameFull: Nakamura R
      – PersonEntity:
          Name:
            NameFull: Sambe T
      – PersonEntity:
          Name:
            NameFull: Ozaki T
      – PersonEntity:
          Name:
            NameFull: Schiavon G
      – PersonEntity:
          Name:
            NameFull: Howell SJ
      – PersonEntity:
          Name:
            NameFull: Toi M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025 Jan
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1880-4233
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Breast cancer (Tokyo, Japan)
              Type: main
ResultId 1